Co-Authors
This is a "connection" page, showing publications co-authored by KHANDAN KEYOMARSI and RACHEL M. LAYMAN.
Connection Strength
0.378
-
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study. Int J Cancer. 2022 06 15; 150(12):2025-2037.
Score: 0.216
-
Inhibiting CDK in Cancer Therapy: Current Evidence and Future Directions. Target Oncol. 2018 02; 13(1):21-38.
Score: 0.163